Castle Biosciences Presents TissueCypher Barrett's Esophagus Data at ACG 2026
Castle Biosciences presented data at the ACG 2026 meeting showing its TissueCypher test identifies Barrett's esophagus patients at elevated risk of progression beyond what biopsy pathology shows.
2newsrooms
2articles
under an hourrunning
Oct 12first seen
Ask Scout
Scout answers questions about this story using only the coverage below.
Coverage over time
Articles
| Oct 12, 1:40 PM | investing.com | Castle Biosciences presents Barrett’s esophagus test data at ACG |
| Oct 12, 1:30 PM | starlocalmedia.com | ACG 2026 Data Show TissueCypher® Identifies Elevated Risk of Progression Beyond Pathology Findings in Barrett's Esophagus |